Fcmr−/− mice receiving B16 transplants exhibited less aggressive tumor growth than their Fcmr+/+ littermates and showed prolonged survival (Fig. 1a, Supplementary Fig. 1a). The gene discussed is FCMR; the disease is neoplasm.